3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
4
INDUSTRY
3
Study Type
Interventional
4
Sponsor
Cancer Type
CNS
4
Conditions
Melanoma
19
Neuroblastoma
16
Leukemia
15
Prostatic Neoplasms
14
Lymphoma
12
Multiple Myeloma
10
Breast Neoplasms
10
Lymphoma, Non-Hodgkin
8
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Glioblastoma
8
Neoplasm Metastasis
6
Myelodysplastic Syndromes
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Fallopian Tube Neoplasms
6
Neoplasms
5
Hodgkin Disease
5
Carcinoma, Non-Small-Cell Lung
5
Uveal Melanoma
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Kidney Neoplasms
4
Glioma
4
Carcinoma, Renal Cell
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms, Male
4
Ovarian Neoplasms
3
Neoplasms, Plasma Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Interventions
Temozolomide
109
Magnetic Resonance Spectroscopy
52
Bevacizumab
52
Radiotherapy
44
Irinotecan
27
Blood Specimen Collection
19
Surgical Procedures, Operative
16
Radiation
15
Aminolevulinic Acid
15
Carboplatin
13
fluorodopa F 18
12
Nivolumab
12
Radiotherapy, Intensity-Modulated
11
Carmustine
11
Radiosurgery
10
Magnetic Resonance Imaging
10
pembrolizumab
9
Topotecan
9
Specimen Handling
9
Everolimus
9
Erlotinib Hydrochloride
9
Biopsy
9
poly ICLC
8
Surveys and Questionnaires
8
Standard of Care
8
Etoposide
8
Drug Therapy
8
Lomustine
7
Filgrastim
7
Cyclophosphamide
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
OTHER
×
Glioma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT03334305
2026-04-23
ACTION
University of Florida
Phase 1
Terminated
18 enrolled
11 charts
NCT02465268
2025-01-14
ATTAC-II
University of Florida
Phase 2
Completed
175 enrolled
18 charts
NCT03615404
2021-01-28
ATTAC-P
Duke University
Phase 1
Completed
11 enrolled
7 charts
NCT03392545
2019-07-11
InSituVac1
Beijing Tiantan Hospital
Phase 1
Unknown
30 enrolled